The role of OCT-A in retinal disease management

Forskningsoutput: TidskriftsbidragÖversiktsartikel


Optical coherence tomography angiography (OCT-A) is a non-invasive, non-dye-based imaging modality that has the potential to enhance our understanding of retinal diseases. While this rapidly advancing imaging modality offers great potential, there is a need for community-wide understanding of the range of technologies and methods for interpreting the images, as well as a need to enhance understanding of images from disease-free eyes for reference when screening for retinal diseases. Importantly, clinical trials have been designed without OCT-A-based endpoints; therefore, caution is required when making treatment decisions based on OCT-A imaging alone. With this in mind, a full understanding of the advantages and limitations of OCT-A will be vital for effective development of the technique within the field of ophthalmology. On behalf of the Vision Academy Steering Committee (sponsored by Bayer), this publication summarizes the views of the authors on the current use of OCT-A imaging and explores its potential for future applications in research and clinical practice.


  • Francisco J. Rodríguez
  • Giovanni Staurenghi
  • Richard Gale
  • Monica Lövestam-Adrian (Medarbetare)
  • On behalf of the Vision Academy Steering Committee
Externa organisationer
  • Luigi Sacco University Hospital
  • University of York
  • Skåne University Hospital
  • Rosario University


Sidor (från-till)2019-2026
TidskriftGraefe's Archive for Clinical and Experimental Ophthalmology
Utgåva nummer11
StatusPublished - 2018 nov 1
Peer review utfördJa
Externt publiceradJa